Research output per year
Research output per year
Personal profile
Research areas
- I study the biological understanding of maladaptive neuropsychiatric diseases such as: anxiety, obsessive-compulsive disorder, post-traumatic stress syndrome. As well as the pharmacological and biological effects of novel treatment options.
- I am very experienced within translational pharmacology, in vitro kinetics, preclinical PK/PD, in vivo imaging, animal models and behavioral pharmacology. I have experience from multiple disease areas, with my main interest being neuropsychiatry.
- I am often engaged in public outreach, a cited expert in the public media, public presentation and have appearances in several scientific documentaries.
- I take mentoring and leadership very seriously, I enjoy leading a diverse team, take pride in developing the next generation of excellent scientists and have a positive attitude towards a healthy work-life balance for all.
External positions
Researcher, Rigshospitalet
1. Nov 2016 → …
Research areas
- Nuclear medicine
- Pharmacology
- Development of new drugs
- Neurobiology
- Depression
Fingerprint
Dive into the research topics where Mikael Palner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans
Cumming, P., Scheidegger, M., Dornbierer, D., Palner, M., Quednow, B. B. & Martin-Soelch, C., 22. Apr 2021, In: Molecules. 26, 9, 2451.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile192 Downloads (Pure) -
Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats
Casado-Sainz, A., Gudmundsen, F., Baerentzen, S. L., Lange, D., Ringsted, A., Martinez-Tejada, I., Medina, S., Lee, H., Svarer, C., Keller, S. H., Schain, M., Kjaerby, C., Fisher, P. M., Cumming, P. & Palner, M., 2022, In: Neuropsychopharmacology. 47, 2, p. 454–464Research output: Contribution to journal › Journal article › Research › peer-review
Open Access -
A single dose of psilocybin induces lasting changes in metabolic connectivity within biologically informed rat brain networks related to compulsions and anxiety.
Gudmundsen, F., Jessen, N. S., Baun, C., Herth, M. M., Shalgunov, V., Fisher, P. M. & Palner, M., 28. May 2024Research output: Other contribution › Research
Open Access -
Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Cameron, L. P., Benetatos, J., Lewis, V., Bonniwell, E. M., Jaster, A. M., Moliner, R., Castrén, E., McCorvy, J. D., Palner, M. & Aguilar-Valles, A., 8. Nov 2023, In: Journal of Neuroscience. 43, 45, p. 7472-7482Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile103 Downloads (Pure) -
Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats
Kiilerich, K. F., Lorenz, J., Scharff, M. B., Speth, N., Brandt, T. G., Czurylo, J., Xiong, M., Jessen, N. S., Casado-Sainz, A., Shalgunov, V., Kjaerby, C., Satała, G., Bojarski, A. J., Jensen, A. A., Herth, M. M., Cumming, P., Overgaard, A. & Palner, M., 2. Oct 2023, In: Molecular Psychiatry. 28, 9, p. 3829-3841Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile181 Downloads (Pure)
Press/Media
-
-
-
Er stoffet fra magiske svampe det nye vidundermiddel mod depression og angst? 'Alt taler for, at vi skal bruge det'
28/09/2024
1 Media contribution
Press/Media: Press / Media
-
-
Tilbageslag for MDMA-terapi: Stor ansøgning om godkendelse dumpet i USA
14/08/2024
1 Media contribution
Press/Media: Press / Media